Petersen J - Search Results

1

Control of cccDNA function in hepatitis B virus infection.

Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Levrero M, et al. Among authors: petersen j. J Hepatol. 2009 Sep;51(3):581-92. doi: 10.1016/j.jhep.2009.05.022. Epub 2009 Jun 10. J Hepatol. 2009. PMID: 19616338 Free article. Review.

2

Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection.

Kowdley KV, Sundaram V, Jeon CY, Qureshi K, Latt NL, Sahota A, Lott S, Curry MP, Tsai N, Chaiyakunapruk N, Lee Y, Petersen J, Buggisch P. Kowdley KV, et al. Among authors: petersen j. Hepatology. 2017 Apr;65(4):1094-1103. doi: 10.1002/hep.29005. Epub 2017 Feb 25. Hepatology. 2017. PMID: 28027579 Review.

3

Flares during long-term entecavir therapy in chronic hepatitis B.

Chi H, Arends P, Reijnders JG, Carey I, Brown A, Fasano M, Mutimer D, Deterding K, Oo YH, Petersen J, van Bommel F, de Knegt RJ, Santantonio TA, Berg T, Welzel TM, Wedemeyer H, Buti M, Pradat P, Zoulim F, Hansen BE, Janssen HL; VIRGIL Surveillance Study Group (European surveillance network for vigilance against viral resistance). Chi H, et al. Among authors: petersen j. J Gastroenterol Hepatol. 2016 Nov;31(11):1882-1887. doi: 10.1111/jgh.13377. J Gastroenterol Hepatol. 2016. PMID: 27008918

4

Efficacy and safety of sofosbuvir-based triple therapy in hepatitis C genotype 4 infection.

Wehmeyer MH, Jordan S, Lüth S, Hartl J, Stoehr A, Eißing C, Lohse AW, Petersen J, Buggisch P, Schulze Zur Wiesch J. Wehmeyer MH, et al. Among authors: petersen j. Dig Liver Dis. 2015 Sep;47(9):811-4. doi: 10.1016/j.dld.2015.05.018. Epub 2015 May 24. Dig Liver Dis. 2015. PMID: 26091766

5

Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs.

Petersen J, Buti M. Petersen J, et al. Expert Rev Gastroenterol Hepatol. 2012 Dec;6(6):683-93; quiz 694. doi: 10.1586/egh.12.52. Expert Rev Gastroenterol Hepatol. 2012. PMID: 23237254 Review.

6

Small animal model systems for studying hepatitis B virus replication and pathogenesis.

Dandri M, Lutgehetmann M, Volz T, Petersen J. Dandri M, et al. Among authors: petersen j. Semin Liver Dis. 2006 May;26(2):181-91. doi: 10.1055/s-2006-939760. Semin Liver Dis. 2006. PMID: 16673296 Review.

7

Hepatitis B virus cccDNA clearance: killing for curing?

Dandri M, Petersen J. Dandri M, et al. Among authors: petersen j. Hepatology. 2005 Dec;42(6):1453-5. doi: 10.1002/hep.20976. Hepatology. 2005. PMID: 16317676

8

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, Trepo C, Marcellin P, Goodman Z, Delaney WE 4th, Xiong S, Brosgart CL, Chen SS, Gibbs CS, Zoulim F. Werle-Lapostolle B, et al. Among authors: petersen j. Gastroenterology. 2004 Jun;126(7):1750-8. doi: 10.1053/j.gastro.2004.03.018. Gastroenterology. 2004. PMID: 15188170

9

Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment.

Zöllner B, Petersen J, Schäfer P, Schröter M, Laufs R, Sterneck M, Feucht HH. Zöllner B, et al. Among authors: petersen j. Clin Infect Dis. 2002 May 1;34(9):1273-7. doi: 10.1086/339959. Epub 2002 Apr 2. Clin Infect Dis. 2002. PMID: 11941556 Clinical Trial.

10

Viral features of lamivudine resistant hepatitis B genotypes A and D.

Zöllner B, Petersen J, Puchhammer-Stöckl E, Kletzmayr J, Sterneck M, Fischer L, Schröter M, Laufs R, Feucht HH. Zöllner B, et al. Among authors: petersen j. Hepatology. 2004 Jan;39(1):42-50. doi: 10.1002/hep.20016. Hepatology. 2004. PMID: 14752821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results